Impact of Tobacco Smoking on Outcomes in Patients with Metastatic Non-Small Cell Lung Cancer in the Era of Targeted Therapy

被引:1
作者
Gutierrez, M. [1 ]
Wozniak, A. [2 ]
Langer, C. [3 ]
Fang, B. [4 ]
Suero-Abreu, G. [5 ]
Norden, A. [6 ]
Bedell, K. [6 ]
Schaffer, J. [6 ]
Collins, A. [6 ]
Schultz, E. [6 ]
Stone, B. [6 ]
Narayanan, V. [6 ]
Goldberg, S. [6 ]
机构
[1] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA
[2] Karmanos Canc Inst, Detroit, MI USA
[3] Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA
[4] Reg Canc Care Associates, East Brunswick, NJ USA
[5] Rutgers State Univ, New Jersey Med Sch, New Brunswick, NJ USA
[6] Cota Inc, New York, NY USA
关键词
smokers; Real world data; non-small cell lung cancer;
D O I
10.1016/j.jtho.2018.08.1096
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2.01-42
引用
收藏
页码:S680 / S681
页数:2
相关论文
共 50 条
[41]   Beyond chemotherapy and targeted therapy: adoptive cellular therapy in non-small cell lung cancer [J].
Wang, Junying ;
Wang, Xueju .
MOLECULAR BIOLOGY REPORTS, 2014, 41 (09) :6317-6323
[43]   Comparison of inflammatory indices in patients with metastatic non-small cell lung cancer [J].
Urakci, Zuhat ;
Oruc, Zeynep ;
Koemek, Halil ;
Ebinc, Senar ;
Pirincci, Esra ;
Kalkan, Ziya ;
Tasdemir, Bekir ;
Kaplan, Muhammet Ali ;
Kuecuekoener, Mehmet ;
Isikdogan, Abdurrahman .
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2025, 71 (04)
[44]   Impact of smoking amount on clinicopathological features and survival in non-small cell lung cancer [J].
Ban, Woo Ho ;
Yeo, Chang Dong ;
Han, Solji ;
Kang, Hye Seon ;
Park, Chan Kwon ;
Kim, Ju Sang ;
Kim, Jin Woo ;
Kim, Seung Joon ;
Lee, Sang Haak ;
Kim, Sung Kyoung .
BMC CANCER, 2020, 20 (01)
[45]   Impact of smoking amount on clinicopathological features and survival in non-small cell lung cancer [J].
Woo Ho Ban ;
Chang Dong Yeo ;
Solji Han ;
Hye Seon Kang ;
Chan Kwon Park ;
Ju Sang Kim ;
Jin Woo Kim ;
Seung Joon Kim ;
Sang Haak Lee ;
Sung Kyoung Kim .
BMC Cancer, 20
[46]   Real-world treatment patterns, biomarker testing, and clinical outcomes of metastatic non-small cell lung cancer patients in the immunotherapy era [J].
Apter, Lior ;
Moser, Sarah Sharman ;
Arunachalam, Ashwini ;
Gazit, Sivan ;
Hoshen, Moshe ;
Chodick, Gabriel ;
Siegelmann-Danieli, Nava .
FRONTIERS IN ONCOLOGY, 2024, 14
[47]   The prognostic impact of the amount of tobacco smoking in non-small cell lung cancer-Differences between adenocarcinoma and squamous cell carcinoma [J].
Okamoto, Tatsuro ;
Suzuki, Yuzo ;
Fujishita, Takatoshi ;
Kitahara, Hirokazu ;
Shimamatsu, Shinichiro ;
Kohno, Mikihiro ;
Morodomi, Yosuke ;
Kawano, Daigo ;
Maehara, Yoshihiko .
LUNG CANCER, 2014, 85 (02) :125-130
[48]   Multi-targeted antifolate therapy for non-small cell lung cancer and mesothelioma [J].
Le Chevalier, T .
ANTI-CANCER DRUGS, 2001, 12 :S21-S25
[49]   EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab [J].
Reade, Chad A. ;
Ganti, Apar Kishor .
BIOLOGICS-TARGETS & THERAPY, 2009, 3 :215-224
[50]   Primary tumor resection of non-small cell lung cancer patients with ipsilateral pleural dissemination (M1a) in the era of targeted therapy [J].
Li, Hao ;
Liu, Taorui ;
Sun, Zewen ;
Yang, Fan .
THORACIC CANCER, 2020, 11 (11) :3213-3222